InvestorsHub Logo
Followers 0
Posts 213
Boards Moderated 0
Alias Born 07/31/2017

Re: None

Wednesday, 08/30/2017 5:29:46 PM

Wednesday, August 30, 2017 5:29:46 PM

Post# of 18220
In the August 25, 2017 8-K under Item 8.01 Other Events there is the indication that IMUN (the Company) issued a press release on August 24, 2017 announcing that its majority owned subsidiary, Cytocom, Inc. has appointed Dr. John Abeles as its Chairman, Director and CEO. In the June 30, 2017 10-Q the IMUN ownership of Cytocom, Inc. is either 12.8% or 11.3%, neither of which would be a majority ownership. What is the correct ownership and does management consider these percentages majority ownership?